Michael B. Brenner
34Patents
12h-index
37Co-inventors
81Inventor score
Filing activity: Jul 3, 1986 → Dec 6, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5679347A | Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods | Chemistry; Metallurgy | 55 | Expired |
| US5610281A | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes | Emerging Cross-Sectional Technologies | 43 | Expired |
| US5445940A | Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease | Physics | 27 | Expired |
| US6300080A | Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5594120A | Integrin alpha subunit | Human Necessities | 25 | Expired |
| US5185250A | Human .gamma., .delta.T cell antigen receptor polypeptides and nucleic acids | Chemistry; Metallurgy | 19 | Expired |
| US6277872A | Oxadiazoles, processes for their preparation and their use as medicaments | Chemistry; Metallurgy | 17 | Expired |
| US6238676A | Presentation of hydrophobic antigens to T-cells by CD1 molecules | Chemistry; Metallurgy | 16 | Expired |
| US5853737A | Method for inducing a CD1-restricted immune response | Chemistry; Metallurgy | 16 | Expired |
| US5024940A | Nucleic acids encoding the delta chain of the T cell antigen receptor | Chemistry; Metallurgy | 14 | Expired |
| US5260223A | Methods for detection of human gamma, .gamma. T cell receptor | Chemistry; Metallurgy | 14 | Expired |
| US6255327A | Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions | Chemistry; Metallurgy | 12 | Expired |
| US6787136B1 | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6406870B2 | Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7029676B2 | Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5747036A | Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease | Physics | 6 | Expired |
| US5340921A | .GAMMA., .delta.T cell receptor and methods and detection | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5627047A | Astrocyte-specific transcription of human genes | Chemistry; Metallurgy | 5 | Expired |
| US6063906A | Antibodies to integrin alpha subunit | Human Necessities | 5 | Expired |
| US6057423A | Integrin alpha subunit | Human Necessities | 5 | Expired |
| US5601822A | .gamma., .delta. T cell receptor and methods for detection | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6455042B1 | Method of treating ulcerative colitis or crohn's disease by administering an antibody to&agr;E&bgr;7 integrin | Human Necessities | 4 | Expired |
| US6964768B2 | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7063844B2 | Presentation of hydrophobic antigens to T-cells by CD1 molecules | Chemistry; Metallurgy | 3 | Expired |
| US7488478B2 | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.